Intervacc is trading at €0.07, up 5.78%, with no confirmed catalyst identified.
- The company announced participation in the Swiss Nordic Bio Conference on October 1, but the routine investor-event notice does not clearly explain the move.
- Shares declined 7.19% on September 14, 2026, during a volatile recent stretch.
- Broader markets were modestly lower, offering limited support from global sentiment.